Rankings
▼
Calendar
ORKA Q3 2024 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ORKA
Oruka Therapeutics, Inc.
$1B
Q3 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$29M
Net Income
-$29M
EPS (Diluted)
$-1.91
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$35M
Free Cash Flow
-$35M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$414M
Total Liabilities
$72M
Stockholders' Equity
$342M
Cash & Equivalents
$411M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$30,000
+100.0%
Operating Income
-$29M
-$2M
-1420.3%
Net Income
-$29M
-$1M
-1910.0%
← FY 2024
All Quarters
Q4 2024 →